Publicaciones en las que colabora con HÉCTOR JOSÉ BUENO ZAMORA (22)

2024

  1. Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial

    JAMA network open, Vol. 7, Núm. 3, pp. e240809

2023

  1. Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non-ST-Segment Elevation Acute Myocardial Infarction: A Randomized Clinical Trial

    JAMA Internal Medicine, Vol. 183, Núm. 5, pp. 407-415

2022

  1. CD69 expression on regulatory T cells protects from immune damage after myocardial infarction

    The Journal of clinical investigation, Vol. 132, Núm. 21

  2. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice

    Revista Española de Cardiología (English Edition), Vol. 75, Núm. 5, pp. 364-369

2021

  1. A novel circulating microRNA for the detection of acute myocarditis

    New England Journal of Medicine, Vol. 384, Núm. 21, pp. 2014-2027

  2. Baseline CHA2DS2-VASc score and prognosis in octogenarians with non-ST segment elevation acute coronary syndrome

    International Journal of Clinical Practice, Vol. 75, Núm. 6

  3. Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 378-383

2020

  1. Comments on the 2019 ESC guidelines on acute pulmonary embolism

    Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 452-456

  2. Comments on the 2019 ESC guidelines on supraventricular tachycardia

    Revista Espanola de Cardiologia, Vol. 73, Núm. 6, pp. 445-451

2019

  1. 2018 ESC/EACTS Guidelines on myocardial revascularization

    European Journal of Cardio-thoracic Surgery, Vol. 55, Núm. 1, pp. 4-90

  2. 2018 ESC/EACTS Guidelines on myocardial revascularization

    European Heart Journal, Vol. 40, Núm. 2, pp. 87-165

  3. Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 154-159

  4. Mitral Regurgitation and Prognosis After Non-ST-Segment Elevation Myocardial Infarction in Very Old Patients

    Journal of the American Geriatrics Society, Vol. 67, Núm. 8, pp. 1641-1648

  5. Safety of drug-eluting stents compared to bare metal stents in patients with an indication for long-term oral anticoagulation: A propensity score matched analysis

    Thrombosis Research, Vol. 177, pp. 180-186

2018

  1. Comments on the 2018 ESC Guidelines for the Diagnosis and Management of Syncope

    Revista Espanola de Cardiologia, Vol. 71, Núm. 10, pp. 787-793

2016

  1. Effects of triple therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention regarding thromboembolic risk stratification

    Circulation Journal, Vol. 80, Núm. 2, pp. 354-362

  2. Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

    PloS one, Vol. 11, Núm. 1, pp. e0147245

2015

  1. Guía de práctica clínica de la ESC sobre revascularización miocárdica, 2014

    Revista Espanola de Cardiologia, Vol. 68, Núm. 2, pp. 144.e-144.e

2014

  1. 2014 ESC/EACTS Guidelines on myocardial revascularization

    European Journal of Cardio-thoracic Surgery, Vol. 46, Núm. 4, pp. 517-592

  2. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

    European Heart Journal, Vol. 35, Núm. 37, pp. 2541-2619